Yikes- sorry- just one more bit! The company did put out two good ANN's after the big Bayer crash. Jenny still got deals done even as the company as we knew it, was winding down.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come